Tumor Necrosis Factor Ligand Superfamily Member 14
"Tumor Necrosis Factor Ligand Superfamily Member 14" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of tumor necrosis factor superfamily found on activated LYMPHOCYTES and MONOCYTES. It occurs as transmembrane protein that can be cleaved to release a secreted form that specifically binds to LYMPHOTOXIN BETA RECEPTOR and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14.
MeSH Number(s)
D12.644.276.374.750.690
D12.644.276.972.690
D12.776.467.374.750.690
D12.776.467.972.690
D23.529.374.750.690
D23.529.972.690
Concept/Terms
Tumor Necrosis Factor Ligand Superfamily Member 14- Tumor Necrosis Factor Ligand Superfamily Member 14
- HVEM-L Protein
- HVEM L Protein
- TNF Superfamily, Member 14
- TNFSF14 Protein
- Herpesvirus Entry Mediator-Ligand Protein
- Herpesvirus Entry Mediator Ligand Protein
- LIGHT Protein
Below are MeSH descriptors whose meaning is more general than "Tumor Necrosis Factor Ligand Superfamily Member 14".
Below are MeSH descriptors whose meaning is more specific than "Tumor Necrosis Factor Ligand Superfamily Member 14".
This graph shows the total number of publications written about "Tumor Necrosis Factor Ligand Superfamily Member 14" by people in Harvard Catalyst Profiles by year, and whether "Tumor Necrosis Factor Ligand Superfamily Member 14" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
Below are the most recent publications written about "Tumor Necrosis Factor Ligand Superfamily Member 14" by people in Profiles.
-
Analysis of Slow-Cycling Variants of the Light-Inducible Nuclear Protein Export System LEXY in Mammalian Cells. ACS Synth Biol. 2022 Oct 21; 11(10):3529-3533.
-
Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci Transl Med. 2021 07 14; 13(602).
-
LTßR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016 08 05; 7:12369.
-
[Regulation mechanism of autophagy-related protein LC3 by c-Jun in methotrexate resistant human choriocarcinoma JEG-3 cells]. Zhonghua Fu Chan Ke Za Zhi. 2014 Jul; 49(7):531-5.
-
Adeno-associated virus-mediated local delivery of LIGHT suppresses tumorigenesis in a murine cervical cancer model. J Immunother. 2011 Oct; 34(8):581-7.
-
Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy. Cancer Gene Ther. 2010 Oct; 17(10):730-41.
-
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev. 2009 May; 229(1):244-58.
-
Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study. Neuro Oncol. 2008 Feb; 10(1):52-60.
-
Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science. 2007 Apr 13; 316(5822):285-8.
-
LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes. Arthritis Rheum. 2007 Apr; 56(4):1106-17.